Cargando…
Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda
BACKGROUND: The diagnosis of extrahepatic obstructive jaundice (EHOJ) remains a challenge and is often made late in low-resource settings. Systematic data are limited on the etiology and prognosis of patients with obstructive jaundice in Uganda. The objective of this study was to determine the etiol...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199528/ https://www.ncbi.nlm.nih.gov/pubmed/35721671 http://dx.doi.org/10.2147/CEG.S356977 |
_version_ | 1784727858569019392 |
---|---|
author | Odongo, Charles Newton Dreque, Carlos Cabrera Mutiibwa, David Bongomin, Felix Oyania, Felix Sikhondze, Mvuyo Maqhawe Acan, Moses Atwine, Raymond Kirya, Fred Situma, Martin |
author_facet | Odongo, Charles Newton Dreque, Carlos Cabrera Mutiibwa, David Bongomin, Felix Oyania, Felix Sikhondze, Mvuyo Maqhawe Acan, Moses Atwine, Raymond Kirya, Fred Situma, Martin |
author_sort | Odongo, Charles Newton |
collection | PubMed |
description | BACKGROUND: The diagnosis of extrahepatic obstructive jaundice (EHOJ) remains a challenge and is often made late in low-resource settings. Systematic data are limited on the etiology and prognosis of patients with obstructive jaundice in Uganda. The objective of this study was to determine the etiology, clinical presentations, and short-term treatment outcomes of patients managed for EHOJ at Mbarara Regional Referral Hospital (MRRH) in south-western Uganda. METHODS: Between September 2019 and May 2020, we prospectively enrolled a cohort of patients who presented with EHOJ at MRRH. A pretested, semi-structured data collection tool was used to abstract data from both the study participants and their files. RESULTS: A total of 72 patients, 42 (58.3%) of whom were male with a median age of 56 (range of 2 months to 95 years) were studied. Forty-two (58.3%) participants had malignancies: Pancreatic head tumors 20 (27.8%), cholangiocarcinoma 13 (18.1%), duodenal cancers 5 (6.94%), and gall bladder cancer 4 (5.6%). The remaining 30 (41.7%) participants had benign etiologies: choledocholithiasis 10 (13.9%), biliary atresia 7 (9.7%), pancreatic pseudo cyst 6 (8.3%), Mirizzi syndrome 5 (6.9%) and 1 (1.4%) each of chronic pancreatitis and choledochal cyst. Sixty-seven (93.1%) patients presented with right upper quadrant tenderness, 65 (90.3%) abdominal pain and 55 (76.3%) clay-colored stool. Cholecystectomy 11 (25.6%) and cholecystojejunostomy + jejunojejunostomy 8 (18.6%) were the commonest procedures performed. Twelve (17.0%) of cases received chemotherapy (epirubicin/cisplatin/capecitabine) for pancreatic head tumors and (gemcitabine/oxaliplatine) for cholangiocarcinoma. Mortality rate was 29.2% in the study, of which malignancy carried the highest mortality 20 (95.24%). CONCLUSION: Malignancy was the main cause of EHOJ observed in more than half of the patients. Interventions aimed at early recognition and appropriate referral are key in this population to improve outcomes. |
format | Online Article Text |
id | pubmed-9199528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-91995282022-06-16 Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda Odongo, Charles Newton Dreque, Carlos Cabrera Mutiibwa, David Bongomin, Felix Oyania, Felix Sikhondze, Mvuyo Maqhawe Acan, Moses Atwine, Raymond Kirya, Fred Situma, Martin Clin Exp Gastroenterol Original Research BACKGROUND: The diagnosis of extrahepatic obstructive jaundice (EHOJ) remains a challenge and is often made late in low-resource settings. Systematic data are limited on the etiology and prognosis of patients with obstructive jaundice in Uganda. The objective of this study was to determine the etiology, clinical presentations, and short-term treatment outcomes of patients managed for EHOJ at Mbarara Regional Referral Hospital (MRRH) in south-western Uganda. METHODS: Between September 2019 and May 2020, we prospectively enrolled a cohort of patients who presented with EHOJ at MRRH. A pretested, semi-structured data collection tool was used to abstract data from both the study participants and their files. RESULTS: A total of 72 patients, 42 (58.3%) of whom were male with a median age of 56 (range of 2 months to 95 years) were studied. Forty-two (58.3%) participants had malignancies: Pancreatic head tumors 20 (27.8%), cholangiocarcinoma 13 (18.1%), duodenal cancers 5 (6.94%), and gall bladder cancer 4 (5.6%). The remaining 30 (41.7%) participants had benign etiologies: choledocholithiasis 10 (13.9%), biliary atresia 7 (9.7%), pancreatic pseudo cyst 6 (8.3%), Mirizzi syndrome 5 (6.9%) and 1 (1.4%) each of chronic pancreatitis and choledochal cyst. Sixty-seven (93.1%) patients presented with right upper quadrant tenderness, 65 (90.3%) abdominal pain and 55 (76.3%) clay-colored stool. Cholecystectomy 11 (25.6%) and cholecystojejunostomy + jejunojejunostomy 8 (18.6%) were the commonest procedures performed. Twelve (17.0%) of cases received chemotherapy (epirubicin/cisplatin/capecitabine) for pancreatic head tumors and (gemcitabine/oxaliplatine) for cholangiocarcinoma. Mortality rate was 29.2% in the study, of which malignancy carried the highest mortality 20 (95.24%). CONCLUSION: Malignancy was the main cause of EHOJ observed in more than half of the patients. Interventions aimed at early recognition and appropriate referral are key in this population to improve outcomes. Dove 2022-06-11 /pmc/articles/PMC9199528/ /pubmed/35721671 http://dx.doi.org/10.2147/CEG.S356977 Text en © 2022 Odongo et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Odongo, Charles Newton Dreque, Carlos Cabrera Mutiibwa, David Bongomin, Felix Oyania, Felix Sikhondze, Mvuyo Maqhawe Acan, Moses Atwine, Raymond Kirya, Fred Situma, Martin Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda |
title | Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda |
title_full | Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda |
title_fullStr | Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda |
title_full_unstemmed | Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda |
title_short | Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda |
title_sort | etiology, clinical presentations, and short-term treatment outcomes of extrahepatic obstructive jaundice in south-western uganda |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199528/ https://www.ncbi.nlm.nih.gov/pubmed/35721671 http://dx.doi.org/10.2147/CEG.S356977 |
work_keys_str_mv | AT odongocharlesnewton etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda AT drequecarloscabrera etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda AT mutiibwadavid etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda AT bongominfelix etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda AT oyaniafelix etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda AT sikhondzemvuyomaqhawe etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda AT acanmoses etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda AT atwineraymond etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda AT kiryafred etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda AT situmamartin etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda |